Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2011
10/12/2011EP2374883A1 Anti-cd4 antibody
10/12/2011EP2374825A1 Photodynamic therapeutic agent showing accumulation of cell-specific functions
10/12/2011EP2374820A2 Human monoclonal antibody having fat-reducing effect
10/12/2011EP2374819A1 Antibodies to MASP-2
10/12/2011EP2374818A1 High affinity antibodies to human IL-6 receptor
10/12/2011EP2374817A1 Anti-P-selectin antibodies
10/12/2011EP2374816A1 Binding molecules against Chikungunya virus and uses thereof
10/12/2011EP2374814A2 Peptides that ellicit T cellular immunity
10/12/2011EP2374811A1 IgG Fc/HIV-gp120/c3d fusion protein
10/12/2011EP2374477A1 Antigen delivery vectors and constructs
10/12/2011EP2374476A1 Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
10/12/2011EP2374475A1 Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
10/12/2011EP2374474A1 Compositions comprising pathogen-associated molecular patterns and antigens and their use to stimulate an immune response
10/12/2011EP2374473A1 Dimensional analysis of saccharide conjugates with GPC & SEC-MALS
10/12/2011EP2374467A1 Protective staphylococcus aureus vaccine based on cell wall-associated proteins
10/12/2011EP2374466A1 Protective staphylococcus aureus vaccine based on cell wall-associated proteins
10/12/2011EP2374001A2 Antibody design using anti-lipid antibody crystal structures
10/12/2011EP2373998A1 Nitroprotein biomarkers for copd
10/12/2011EP2373785A1 Bovine viral diarrhea virus with a modified erns protein
10/12/2011EP2373692A1 Dual variable domain immunoglobulins and uses thereof
10/12/2011EP2373691A2 Anti-fxi antibodies and methods of use
10/12/2011EP2373688A1 A monoclonal antibody and its use for the identification of the oncofetal isoform of fibronectin (b-fn) for diagnosis or therapy
10/12/2011EP2373686A2 Msp2 antigenic peptides and their use
10/12/2011EP2373341A1 Subcutaneous administration of anti-hepatitis b antibodies
10/12/2011EP2373340A2 Random homozygous gene perburbation (rhgp) with thermal assymetric interlaced (tail)-pcr
10/12/2011EP2373339A1 A b cell depleting agent for the treatment of atherosclerosis
10/12/2011EP2373338A2 Annexina2 as immunological target
10/12/2011EP2373337A1 Monoclonal antibodies directed against lg4-5 domain of alpha3 chain of human laminin-5
10/12/2011EP2373336A1 Use of an anti-cd20 antibody for treating primary intraocular lymphoma
10/12/2011EP2373335A1 Anti-ferroportin 1 monoclonal antibodies and uses thereof
10/12/2011EP2373334A1 High growth reassortant influenza a virus
10/12/2011EP2373333A1 Ex-vivo passive protection bacteremia assay
10/12/2011EP2373332A1 Process for production of vaccines
10/12/2011EP2373331A2 Albumin binding peptide-mediated disease targeting
10/12/2011EP2373329A2 Use of epidermal growth factor inhibitors in the treatment of viral infection
10/12/2011EP2373298A1 Compound, medicament, vaccine composition and nanocapsules
10/12/2011EP2373293A2 Compositions with reduced dimer formation
10/12/2011EP2017333B1 Feline cell capable of being cultured without animal protein, and method for production of virus and method for production of vaccine using the feline cell
10/12/2011EP1917033B1 Virus-like particles as vaccines for paramyxovirus
10/12/2011EP1652923B1 Gene overexpressed in cancer
10/12/2011EP1487482B1 Dna vaccine against proliferating endothelial cells and methods of use thereof
10/12/2011CN1980638B Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids
10/12/2011CN102216333A C-met antibodies
10/12/2011CN102216332A Use of anti-cs1 antibodies for treatment of rare lymphomas
10/12/2011CN102216329A Treatment of interstitial cystitis
10/12/2011CN102215875A Sustained drug delivery system
10/12/2011CN102215870A Diagnosis method and therapeutic method for cancer
10/12/2011CN102215869A Methods and compositions for regulating iron homeostasis by modulation bmp-6
10/12/2011CN102215868A Methods for treating progressive multiple sclerosis
10/12/2011CN102215867A Composition for treating disease
10/12/2011CN102215866A Vaccine formulations and uses thereof
10/12/2011CN102215865A Methods for purification of viruses
10/12/2011CN102215864A Vaccine composition for use against influenza
10/12/2011CN102215863A Vaccine comprising protein nmbo964 from meisseria meningitidis
10/12/2011CN102215862A Globo h and related anti-cancer vaccines with novel glycolipid adjuvants
10/12/2011CN102215861A Vaccine for cervical cancer
10/12/2011CN102215830A Encapsulation of biologically active agents
10/12/2011CN102212524A Oligodeoxyribonucleotide used as immunomodulator of cattle and pig and vaccine adjuvant
10/12/2011CN102212139A Fusion protein of tick-borne encephalitis virus envelop E protein and human antibody Fc fragment, and application thereof
10/12/2011CN102212138A Tubercle bacillus fusion protein HspX-Mtb8.4 and preparation method and application thereof
10/12/2011CN102212137A Genetically engineered recombinant polypeptide for cloven-hoofed animals
10/12/2011CN102212133A Fab segment of human-source human immunodeficiency virus (HIV) antibody and coded gene and application thereof
10/12/2011CN102212132A Binding molecules capable of neutralizing rabies virus and uses thereof
10/12/2011CN102212131A Binding molecules capable of neutralizing rabies virus and uses thereof
10/12/2011CN102212120A Salmonella paratyphi A PagC subunit vaccine and preparation method thereof
10/12/2011CN102212115A Newly found hepatitis C virus epitope
10/12/2011CN102212114A New hepatitis C virus epitope
10/12/2011CN102212113A Tuberculosis medicament resistance related tuberculosis-resisting cytotoxic T lymphocyte (CTL) epitope peptide derived from refflux protein and application thereof
10/12/2011CN102212112A MTA1 (metastasis-associated gene 1)-derived anti-tumor CTL (cytotoxic T lymphocyte) epitope peptide and application thereof
10/12/2011CN102210875A LAMP-oriented BAP31 vaccine vector capable of inducing immune response and application thereof
10/12/2011CN102210874A Preparation method of HIV (Human Immunodeficiency Virus) recombinant subtype DNA (Deoxyribonucleic Acid) vaccine
10/12/2011CN102210863A Method for preparing yolk immune globulin nanometer liposome for preventing and controlling infectious bursal disease
10/12/2011CN102210862A Livin-based immune-stimulating complex, preparation method thereof and application thereof
10/12/2011CN102210861A Multi-epitope peptide-loaded DC (dendritic cell) therapeutic vaccine for HCV (hepatitis C viruses)
10/12/2011CN102210860A Mycobacterium tuberculosis TB10.4-F1 fusion protein vaccine and preparation method thereof
10/12/2011CN102210859A Mycobacterium tuberculosis ESAT-6-F2 fusion protein subunit vaccine and preparation method thereof
10/12/2011CN102210858A Combined EV71 (enterovirus 71)-HA (hepatitis A) vaccine
10/12/2011CN102210857A Method for improving antigen amount of inactivated porcine circovirus 2 (PCV2) vaccine
10/12/2011CN102210852A Treatment of T-cell mediated diseases
10/12/2011CN102210646A Human rabies vaccine gel and preparation method thereof
10/12/2011CN101659954B Recombinant adenovirus expressing mycoplasma hyopneumoniae P102 protein and applications thereof
10/12/2011CN101626781B Method for preparing cell populations with anti-tumor immune response activity
10/12/2011CN101519448B Epididymal protease inhibitor protein monoclonal antibody and application thereof
10/12/2011CN101466392B Pharmaceutical composition for preventing or curing HIV infection and use thereof
10/12/2011CN101139394B Cytoplasma membrane surface antigen monoclonal antibody and uses thereof
10/11/2011US8034959 Methods of treating cancer with an antibody-drug conjugate
10/11/2011US8034919 Probe, probe set, probe carrier, and testing method
10/11/2011US8034918 Probe, probe set, probe carrier, and testing method
10/11/2011US8034904 First therapeutic agent is an antibody or an epitope-binding fragment having the same amino acid sequence as the murine antibody EM164 produced by mouse hybridoma EM164; a second therapeutical agent selected from carboplatin, oxaliplatin, cisplatin, paclitaxel, docetaxel etc.; anticarcinogenic agents
10/11/2011US8034903 Degraded TPO agonist antibody
10/11/2011US8034784 Method of suppressing or reducing IL-TIF-induced inflammation, or treating associated conditions thereof, using Zcytor16
10/11/2011US8034776 Orallyl administering a zonulin antagonist comprising an octapeptide; monitoring; administering a gluten challenge; diagnosis of celiac disease by determining amount of interferons, interleukins, or nitrates in a sample and evaluating
10/11/2011US8034635 Methods of donor specific crossmatching
10/11/2011US8034378 water; a biodegradable microparticle of a polylactone, polyorthoester, a polyanhydride, or a polycyanoacrylate; an antigen adsorbed to the microparticle; and a phospholipid adjuvant with one or more phosphoric acid or phosphodiester groups and linear alkane groups
10/11/2011US8034360 Use of human prostate cell lines in cancer treatment
10/11/2011US8034359 Tissue targeted antigenic activation of the immune response to cancers
10/11/2011US8034358 Surface antigen
10/11/2011US8034357 Treatment of fine wrinkles with clostridia neurotoxins
10/11/2011US8034356 Monoparamunity inducers based on attenuated rabbit myxoma viruses
10/11/2011US8034355 Attenuated nonsegmented negative-sense RNA viruses with reduced mRNA cap methyltransferase activity comprising mutations within conserved domain VI of the large polymerase